PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Innovative research aims to improve wound healing and cancer therapy

Freiburg researcher Priscilla Briquez receives ERC Starting Grant for innovative approach to protein engineering

Innovative research aims to improve wound healing and cancer therapy
2023-10-27
(Press-News.org)

Jun.-Prof. Dr. Priscilla Briquez, junior professor at the Department of General and Visceral Surgery at the Freiburg University Medical Center and member of the Medical Faculty at the University of Freiburg, has received a European Research Council (ERC) Starting Grant from the European Commission. Her DRESSCODE project will receive a total of 1.5 million euros funding for five years. The project focuses on modifying proteins and developing new disease therapies.

“This support is a major opportunity for me to put together my own team and drive forward my research,” says Briquez. The focus of the project is on equipping protein cell membranes with therapeutic receptors. This produces cells which can perform specific healing functions, such as targeted bonding to medicines or pathogens. “The research project opens up new, significant opportunities for both regenerative medicine and cancer immunotherapy,” says Prof. Dr. Lutz Hein, Dean of the Medical Faculty of the University of Freiburg.

Innovations for wound healing and cancer immunotherapy

In the field of regenerative medicine, Briquez’s research approach can specifically alter the vascular endothelial growth factor (VEGF) receptor-2. This promotes the formation of blood vessels in chronic wounds and assists wound healing. In connection with cancer immunotherapy the project is researching the development of chimeric antigen receptors (CAR) on T-cells. These are receptors that are placed on immune cells in order to identify and attack cancer cells.

Briquez gained her PhD in 2016 at the Ecole Polytechnique Federale of Lausanne (EPFL), where she investigated the development of therapeutic proteins and biomaterials for wound healing. After that she was a postdoc at the Pritzker School of Molecular Engineering of the University of Chicago. There, she devoted herself to the field of molecular immunoengineering and cancer immunotherapy, before moving to the Department of General and Visceral Surgery at the Freiburg University Medical Center in 2021 where she was appointed junior professor.

With its Starting Grant funding line the ERC supports junior researchers who have already done outstanding work and who have the potential to assume a leading role in research.

Contact:
Corporate Communications
Freiburg University Medical Center
Tel. +49 761 270-84830
email: kommunikation@uniklinik-freiburg.de

University and Science Communication
University of Freiburg
Tel. +49 761 203-4302
email: kommunikation@zv.uni-freiburg.de

END


[Attachments] See images for this press release:
Innovative research aims to improve wound healing and cancer therapy Innovative research aims to improve wound healing and cancer therapy 2

ELSE PRESS RELEASES FROM THIS DATE:

Action plan for better data on migration and health

Action plan for better data on migration and health
2023-10-27
Despite rising global mobility, the state of migrant and refugee health data in European health systems is a concern, a new study shows. The analysis by an international coalition of universities, UN organizations, government representatives, and European institutions published in the journal The Lancet Regional Health Europe reveals that coverage of migrant and refugee data remains inconsistent and of suboptimal quality. According to the study this issue is not due to a lack of knowledge or technological resources ...

FDA approves muscular dystrophy drug built on Children’s National research 

2023-10-27
WASHINGTON (October 27, 2023) – Boys with Duchenne muscular dystrophy (DMD) have a clinically proven, new treatment option with the Food and Drug Administration’s approval Thursday of vamorolone, a steroidal-type, anti-inflammatory drug developed based on research performed at Children’s National Hospital.    Created by ReveraGen BioPharma Inc., vamorolone has a molecular structure similar to traditional corticosteroids, which are currently used to treat DMD. Yet its structure was found to be chemically different enough to reduce unwanted side effects, including brittle bones and reduced stature. Nearly two decades ago, ReveraGen leaders – President and ...

Electrodes with hollow nanotubes improve performance of potassium-ion batteries

Electrodes with hollow nanotubes improve performance of potassium-ion batteries
2023-10-27
Researchers who are working to find alternatives to lithium-ion batteries have turned their attention to potassium-ion batteries. Potassium is an abundant resource and the technology functions in much the same way as lithium-ion batteries, but these batteries have not been developed at a large scale because the ionic radius causes problems in energy storage and substandard electrochemical performance.   To solve this problem, researchers are considering NiCo2Se4, a bimetallic selenide, to create sphere-shaped electrodes. The spheres are constructed with NiCo2Se4 nanotubes, which improve ...

USDA grant will help MU researchers address opioid epidemic in rural Missouri

USDA grant will help MU researchers address opioid epidemic in rural Missouri
2023-10-27
COLUMBIA, Mo. -- Childhood trauma is a key risk factor for future substance use disorder, overdose, and suicide. This is particularly problematic in rural areas where children experience higher rates of adverse childhood experiences (ACEs). ACEs are commonly defined as physical and emotional abuse and neglect, sexual abuse, parental separation or divorce, intimate partner violence, and having household members with serious mental illness, substance use disorder, or a history of incarceration. Now, a three-year, U.S. Department of Agriculture (USDA) grant awarded to the University of Missouri will help virtually train various members of the workforce — ...

UiB researchers solve protein mystery

UiB researchers solve protein mystery
2023-10-27
Proteins are key to all processes in our cells and understanding their functions and regulation is of major importance. “For many years, we have known that nearly all human proteins are modified by a specific chemical group, but its functional impact has remained undefined”, says professor Thomas Arnesen at the Department of Biomedicine, University of Bergen. He explains: “One of the most common protein modifications in human cells is N-terminal acetylation, which is an addition of a small chemical group (acetyl) at the starting tip (N-terminus) of a protein. The ...

Protein root discovery seals future of climate proof plants

2023-10-27
Researchers have discovered a protein that seals plant roots to regulate the uptake of nutrients and water from the soil, the discovery could help develop climate proof crops that require less water and chemical fertilizers. Researchers from the University of Nottingham identified new components of the lignin barrier in plant roots and the specific function of dirigent proteins (DPs), located in the root endodermis that control water and nutrient uptake. Their findings have been published today in Science Direct. Plant roots function by absorbing ...

A relational framework for microbiome research that includes Indigenous communities

2023-10-27
Research on the trillions of microorganisms that make up a person’s microbiome can lead to medical breakthroughs to treat diseases like inflammatory bowel syndrome and diabetes. According to Alyssa Bader, a Tsimshian Assistant Professor in the Department of Anthropology at McGill University, microbiome samples from Indigenous communities have the potential to further Western medicine, but those same communities often have been excluded from the research process and may miss out on the benefits that result from their contributions to science. ...

City of Hope part of successful international Phase 3 clinical trial evaluating sotorasib medication combination for patients with metastatic colorectal cancer

City of Hope part of successful international Phase 3 clinical trial evaluating sotorasib medication combination for patients with metastatic colorectal cancer
2023-10-27
LOS ANGELES — An international Phase 3 clinical trial found that metastatic colorectal cancer patients with a rare genetic tumor mutation called KRAS G12C experienced superior progression-free survival rates compared to standard of care when offered a combination treatment of KRAS inhibitor sotorasib and monoclonal antibody panitumumab. City of Hope, one of the largest cancer research and treatment organizations in the United States, was a participating site and a City of Hope researcher is the lead author of the The New England Journal of Medicine study published this week. Standard ...

Team synthesizes a new polyoxometalate-based metal-organic complex

Team synthesizes a new polyoxometalate-based metal-organic complex
2023-10-27
A research team has synthesized a new polyoxometalate-based metal-organic complex that they then tested as a catalyst for the oxidation reactions of various sulfides. They found that the complex possesses excellent catalytic performance, good reusability, and structural stability.   The team’s work is published in the journal Polyoxometalates on October 19, 2023.   Scientists in many fields have explored the selective oxidation of sulfides to sulfoxides. Sulfoxides are organic compounds that contain sulfur and oxygen. These sulfoxides are high value-added chemicals in pharmaceuticals, agrochemistry, ...

The sunscreen paradox: McGill University researchers warn of ‘false sense of security’

2023-10-27
Sunscreen usage is climbing, but so are melanoma and skin cancer rates: this, researchers say, is the sunscreen paradox. “The problem is that people use sunscreen as a ‘permission slip’ to tan,” said Dr. Ivan Litvinov, an Associate Professor in the Department of Medicine and Chair of the Dermatology Division at McGill University and co-author with Dr. Sandra Peláez, Dr. Richie Jeremian and Dr. Pingxing Xie of two recent studies that explore the sunscreen paradox. “People think they are protected from skin cancer ...

LAST 30 PRESS RELEASES:

NCSA director Bill Gropp honored with prestigious ACM award

The future of brain activity monitoring may look like a strand of hair

New gene-editing therapy shows early success in fighting advanced GI cancers

nTIDE May 2025 Jobs Report: Employment of People with Disabilities Remains in a Holding Pattern

SCAI honors members for outstanding service and dedication

NRG Oncology adds new committee leaders in lung cancer and imaging

Sun safety declining in Canada amid rise in skin cancer cases

Pennington Biomedical highlights how cellular quality control contribute to insulin resistance related to type 2 diabetes

ACM honors those who shape technology's future

ESE and ESPE joint event to call for stronger national and EU action on endocrine disruptors

Call for papers: Commemorative collection honoring Dr. Judith Campisi

New studies highlight potential of artificial intelligence to improve outcomes for patients with heart failure and cardiac arrest

Space junk falling to Earth needs to be tracked. Meteoroid sounds can help

Dust in the system — How Saharan storms threaten Europe’s solar power future

“It’s like they have a superpower”: Genetic analysis of all-women extreme divers finds changes linked to blood pressure, cold tolerance

The all-female Korean Haenyeo divers show genetic adaptions to cold water diving

Antivenom neutralizes the neurotoxins of 19 of the world’s deadliest snakes

Postpartum care differences in LGBTQ+ and non-LGBTQ+ individuals

Medicaid unwinding linked to disruptions in opioid addiction treatment

State-level tax policy, cancer screening, and mortality rates in the US

Lactate mediates training of our innate defenses

Sutter Health study highlights the power and potential of ambient AI to improve clinician well-being

How mid-Cretaceous events affected marine top predators

How will 13 million farmers fight back against sea level rise? New global model simulates adaptation, migration, and survival in the face of climate crises

PSU study gauges public's willingness on microplastic interventions

Large-scale heart failure initiative boosts use of lifesaving medications

Two HSS studies exploring pain control win President’s Choice Awards at Annual ASRA Meeting

Novel innovations effectively and safely enable improved blood flow in high-risk patients

Younger patients with asymptomatic aortic stenosis who undergo transcatheter aortic valve replacement experience lower rates of serious cardiovascular events, including stroke

Novel, balloon-assisted anterior mitral leaflet modification shown to be safe and effective for patients undergoing transcatheter mitral valve replacement

[Press-News.org] Innovative research aims to improve wound healing and cancer therapy
Freiburg researcher Priscilla Briquez receives ERC Starting Grant for innovative approach to protein engineering